RebeccaA(Emmons)GardnerMD

PubMed

• 1 citations
  STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid Tumors.
  Navin Pinto, Catherine M Albert, Mallory R Taylor, Heidi B Ullom, Ashley L Wilson
  Journal of Clinical Oncology. 2024-12-10
• Feasibility and Favorable Responses Following Investigational CAR T-Cell Therapy for Relapsed and Refractory Infant ALL.
  Colleen Annesley, Adam J Lamble, Corinne Summers, Michael A Pulsipher, Alan S Wayne
  Blood Advances. 2024-08-12
• 1 citations
  ACT To Sustain: Adoptive Cell Therapy To Sustain Access to Non-Commercialized Genetically Modified Cell Therapies.
  Rebecca A Gardner, Claire White, Magdi Elsallab, Stephanie Farnia, Ellen Fraint
  Transplantation and Cellular Therapy. 2024-08-01

Abstracts/Posters

• Clinical Experience of CAR T Cell Immunotherapy for Relapsed and Refractory Infant ALL Demonstrates Feasibility and Favorable Responses
  Rebecca Gardner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Detailed Multi-Method Analysis of Bone Marrow from Pediatric Pre-B-ALL Patients Prior to CD19-CAR-T Therapy Subsequently Evidencing Overt CAR-T Resistance
  Rebecca Gardner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Novel CD19t T-Antigen Presenting Cells Expand CD19 CAR T Cells In Vivo
  Rebecca Gardner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

• Expanding Horizons for Immunotherapy in Pediatric Leukemia 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019